Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Baxter

Showing results (611-620 of 668) with videos related to

Pageof 67
Sort By:
British Journal of Haematology|August 19, 2011
A comparison of immune reconstitution and graft-versus-host disease following myeloablative conditioning versus reduced toxicity conditioning and umbilical cord blood transplantation in paediatric recipientsMark B Geyer, Judith S Jacobson, Jason Freedman, et al.
BMC Infectious Diseases|July 14, 2021
A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelaeStephanie M LaVergne, Sophia Stromberg, Bridget A Baxter, et al.
Neuro-Oncology|January 29, 2014
A patient tumor-derived orthotopic xenograft mouse model replicating the group 3 supratentorial primitive neuroectodermal tumor in childrenZhigang Liu, Xiumei Zhao, Yue Wang, et al.
Bone Marrow Transplantation|May 7, 2014
Reduced toxicity, myeloablative conditioning with BU, fludarabine, alemtuzumab and SCT from sibling donors in children with sickle cell diseaseM Bhatia, Z Jin, C Baker, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 21, 2021
Evaluation of an EZH2 inhibitor in patient-derived orthotopic xenograft models of pediatric brain tumors alone and in combination with chemo- and radiation therapiesLin Qi, Holly Lindsay, Mari Kogiso, et al.
Human Immunology|May 20, 2008
Strategies and technical challenges in allele level Class II typing in 2578 bone marrow transplantation donor-recipient pairsT M Williams, T Winden, M Setterholm, et al.
British Journal of Cancer|July 4, 2025
AKT/mTOR as a targetable hub to overcome multimodal resistance to EGFR inhibitors in oesophageal squamous cell carcinomaLindsay C Spender, Dale M Watt, Mark A Baxter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2021
A Phase I and Surgical Study of Ribociclib and Everolimus in Children with Recurrent or Refractory Malignant Brain Tumors: A Pediatric Brain Tumor Consortium StudyMariko D DeWire, Christine Fuller, Olivia Campagne, et al.
Tissue Antigens|January 1, 1996
Large-scale DRB and DQB1 oligonucleotide typing for the NMDP registry: progress report from year 2J Ng, C K Hurley, C Carter, et al.
Research in Veterinary Science|December 23, 2018
Evaluation of the antimicrobial and intestinal integrity properties of boric acid in broiler chickens infected with Salmonella enteritidis: Proof of conceptDaniel Hernandez-Patlan, Bruno Solis-Cruz, Bishnu Adhikari, et al.
Pageof 67

Showing results (611-620 of 668) with videos related to

Sort By:
Pageof 67
British Journal of Haematology|August 19, 2011
A comparison of immune reconstitution and graft-versus-host disease following myeloablative conditioning versus reduced toxicity conditioning and umbilical cord blood transplantation in paediatric recipientsMark B Geyer, Judith S Jacobson, Jason Freedman, et al.
BMC Infectious Diseases|July 14, 2021
A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelaeStephanie M LaVergne, Sophia Stromberg, Bridget A Baxter, et al.
Neuro-Oncology|January 29, 2014
A patient tumor-derived orthotopic xenograft mouse model replicating the group 3 supratentorial primitive neuroectodermal tumor in childrenZhigang Liu, Xiumei Zhao, Yue Wang, et al.
Bone Marrow Transplantation|May 7, 2014
Reduced toxicity, myeloablative conditioning with BU, fludarabine, alemtuzumab and SCT from sibling donors in children with sickle cell diseaseM Bhatia, Z Jin, C Baker, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 21, 2021
Evaluation of an EZH2 inhibitor in patient-derived orthotopic xenograft models of pediatric brain tumors alone and in combination with chemo- and radiation therapiesLin Qi, Holly Lindsay, Mari Kogiso, et al.
Human Immunology|May 20, 2008
Strategies and technical challenges in allele level Class II typing in 2578 bone marrow transplantation donor-recipient pairsT M Williams, T Winden, M Setterholm, et al.
British Journal of Cancer|July 4, 2025
AKT/mTOR as a targetable hub to overcome multimodal resistance to EGFR inhibitors in oesophageal squamous cell carcinomaLindsay C Spender, Dale M Watt, Mark A Baxter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2021
A Phase I and Surgical Study of Ribociclib and Everolimus in Children with Recurrent or Refractory Malignant Brain Tumors: A Pediatric Brain Tumor Consortium StudyMariko D DeWire, Christine Fuller, Olivia Campagne, et al.
Tissue Antigens|January 1, 1996
Large-scale DRB and DQB1 oligonucleotide typing for the NMDP registry: progress report from year 2J Ng, C K Hurley, C Carter, et al.
Research in Veterinary Science|December 23, 2018
Evaluation of the antimicrobial and intestinal integrity properties of boric acid in broiler chickens infected with Salmonella enteritidis: Proof of conceptDaniel Hernandez-Patlan, Bruno Solis-Cruz, Bishnu Adhikari, et al.
Pageof 67